Detalhe da pesquisa
1.
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor.
Bioorg Med Chem Lett
; 23(19): 5410-4, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23953189
2.
Identification of a PCSK9-LDLR disruptor peptide with in vivo function.
Cell Chem Biol
; 29(2): 249-258.e5, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547225
3.
In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
Biochem Biophys Res Commun
; 394(2): 366-71, 2010 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211605
4.
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonist.
BMC Pharmacol
; 10: 9, 2010 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20712891
5.
Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice.
Eur J Pharmacol
; 462(1-3): 125-32, 2003 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12591104
6.
Validation of a high-resolution X-ray computed tomography system to measure murine adipose tissue depot mass in situ and longitudinally.
J Pharmacol Toxicol Methods
; 47(2): 99-106, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12459149
7.
Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents.
ACS Med Chem Lett
; 3(5): 397-401, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24900484
8.
Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
Am J Physiol Endocrinol Metab
; 295(5): E1142-51, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18728225
9.
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.
Bioorg Med Chem Lett
; 16(3): 731-6, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16263283